YH
Deputy Director, Division of Molecular Genetics and Pathology, CDRH, FDA
Dr. Hu is currently the Deputy Director of the Division of Molecular Genetics and Pathology in the Office of In Vitro Diagnostics and Radiological Health at FDA. He received his M.S. and Ph.D. degrees from the Ohio State University. He joined FDA in 2009 and was promoted to Associate...
Read More → 
Industry Stakeholder Liaison, Corporate Stakeholders Department, European Medicines Agency (EMA)
Marie-Helene Pinheiro currently the Industry Stakeholder Liaison within the Corporate Stakeholders Department, at the European Medicines Agency. She is responsible for coordinating the Agency’s interaction with industry stakeholder organisations, for human and veterinary medicines...
Read More →MS
Office of Safety I, Pharmaceuticals and Medical Devices Agency (PMDA)
Vice President, Global Regulatory Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson
Karen Weiss MD, MPH is the VP for Regulatory Policy and Intelligence for Janssen Pharmaeutical Companies of J&J. She joined J&J in January 2012 after a 22 year career at the US FDA, where she served in a number of postions, within first CBER and then CDER. Before joining FDA, Karen...
Read More →
